Bongeka Zuma, graduate of Oprah Winfrey’s academy and Stanford School of Medicine, discusses her plans to advance medical care in her hometown.
Category: Ethics
What’s the deal with PFAS, aka ‘forever chemicals’?
The so-called ‘forever chemicals’ can stick around in the environment — and in our bodies. Scientists agree there is cause for concern. So what should we be doing to mitigate our health risks?
Talking about the need for Stanford Medicine’s new Skin of Color program
Leandra Barnes talks about being drawn to dermatology because of its non-inclusionary tendencies, giving her fertile soil to advocate for better care for people of color.
How the tobacco industry began funding courses for doctors
Earlier this year, the largest tobacco company in the world paid millions to fund continuing medical education courses on nicotine addiction —16,000 physicians and other health care providers took them.
How gaps in pediatric obesity treatment make access inequitable
Thomas Robinson wrote an editioral about the new guidelines, outlining what treatments got the top recommendation, and how gaps in the healthcare system make access to the best treatments inequitable.
From farmworker to doctor: A bold dream is reuniting her with her Indigenous community
Gianna Nino-Tapias knows the challenges of migrant farmworkers better than most. Her mother continues to pick blueberries daily. She plans to use her medical degree to help integrate and advocate for better health care.
These are the tools for providing top-notch diabetes care to everyone
Using AI, continuous glucose monitors, and an equity approach, diabetes care could be saving many more lives, Stanford Medicine researchers say.
Inequity of genetic screening: DNA tests fail non-white families more often
Research is showing that advanced methods of genetic testing aren’t equally useful for everyone: They’re less accurate for non-white families, raising concerns about how historical gaps in whose DNA gets studied produce inequities in medical care.
Researchers seek healthy checks and balances for how products are designed
With such conveniences as digital devices at our fingertips comes a messy health conundrum, say Stanford Medicine researchers.
AI, medicine and race: Why ending ‘structural racism’ in health care now is crucial
Health care providers must reckon with inherent race-based biases in medicine, which can reinforce false stereotypes in algorithms and lead to improper treatment recommendations or late diagnoses.
New policy is taking sexual orientation, gender out of blood donor equation
New guidelines will continue to ensure the safety of the nation's blood supply, according to the Food and Drug Administration.
How to regulate AI? Bioethicist David Magnus on medicine’s critical moment
The applications for AI in medicine are being explored deeply at Stanford Medicine and elsewhere. Putting guardrails in place now is crucial.
Rethinking large language models in medicine
Stanford Medicine researchers and leaders discuss the need for medical and health professionals to shape the creation of large language models.
Bringing principles of ethics to AI and drug design
Researchers discuss the need for ethics and its integration into research projects that harness artificial intelligence.
When AI is watching patient care: Ethics to consider
Ethical and legal issues accompany the potential benefits of using computer vision-based ambient intelligence in health care.
Financial transparency may diminish trust in doctors, new study finds
A Stanford study has found that mandated public disclosure of physicians' financial ties may have diminished trust in all physicians.